Dokument: Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
| Titel: | Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=73160 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20260504-121057-9 | |||||||
| Kollektion: | Publikationen | |||||||
| Sprache: | Englisch | |||||||
| Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
| Medientyp: | Text | |||||||
| Autoren: | Voth, Jan [Autor] Gall, Charlotte von [Autor] Werner, Noah M. [Autor] Meuth, Sven G. [Autor] Pawlitzki, Marc [Autor] Masanneck, Lars [Autor] Gmahl, Noëmi [Autor] Hörste, Gerd Meyer zu [Autor] | |||||||
| Dateien: |
| |||||||
| Stichwörter: | sleep efficiency , wearables , sleep monitoring , WASO , CIDP | |||||||
| Beschreibung: | Background and Aims:
Previous studies suggest that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) experience impaired sleep, contributing to fatigue. Traditional methods like polysomnography or questionnaires are resource-intensive and may not capture sleep in natural settings. We explored whether widely available consumer-grade smartwatches offer a feasible way to assess sleep quality in this population. Methods: The Electronic Monitoring of Disease Activity in patients with CIDP (EMDA- CIDP) study was a prospective observational study conducted from January 2023 to July 2024 at the University Hospitals of Düsseldorf and Münster. 46 patients had nighttime sleep recorded for 6 months via smartwatch. Additionally, clinical scores (e.g., Inflammatory Rasch-built Overall Disability Scale), sleep (PSQI, Pittsburgh Sleep Quality Index), and quality of life (QoL) questionnaires were collected every 3 months. Results: Of 46 participants, 40 met adherence criteria (≥ 75% wear time on ≥ 75% of nights, median age: 66 years [IQR: 59.5– 70.3], 9 [22.5%] female). Median PSQI score was 6 (4–7.6), sleep efficiency 93% (92–95), and WASO (wake after sleep onset) 32 min (24–42). Smartwatch-derived objective sleep measures – sleep efficiency and WASO – correlated significantly with PSQI (Spearman's R = −0.49, R = 0.40), clinical scores, and QoL. Interpretation: Sleep is impaired in patients with CIDP and contributes to the overall disease burden. Our findings suggest that sleep disturbances can be tracked longitudinally using smartwatch-derived markers. Integrating digital health data presents promising opportunities for long-term sleep monitoring in this population. Larger studies, ideally incorporating polysomnography, are warranted to validate these findings. | |||||||
| Rechtliche Vermerke: | Originalveröffentlichung:
Voth, J., Gall, C. von, Gmahl, N., Werner, N. M., Hörste, G. M. zu, Meuth, S., Pawlitzki, M., & Masanneck, L. (2025). Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Journal of the Peripheral Nervous System, 30(4), Article e70069. https://doi.org/10.1111/jns.70069 | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
| Dokument erstellt am: | 04.05.2026 | |||||||
| Dateien geändert am: | 04.05.2026 |
